Brief: Tongfang Kontafarma updates on lawsuit involving co's MD
Sept 15 (Reuters) - Tongfang Kontafarma 1312.HK
* Refers to petition involving co's MD in his capacity as
former non-executive director of China Shanshui Cement
* Derivative action is not in relation to group nor in
connection with performance of duties by Ng to group
Source text (http://bit.ly/2wusQge)
Further company coverage: 1312.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China Shanshui Cement
See all newsBrief: China Shanshui Cement Group Posts Q1 Revenue Of RMB 1,175.6 Million
Brief: China Shanshui Cement Says Loss Attributable For 2025 RMB983 Million
Brief: China Shanshui Cement Group Posts H1 Net Income RMB Of -250.2 Million
Brief: China Shanshui Cement Appoints Teng Yongjun As Chairman
Brief: China Shanshui Cement Says HY Loss From Operations RMB500.9 Million